It was revealed that most of the key target genes are associated with the FoxO signaling pathway (Figure 3A) and PI3K/AKT signaling pathway (Figure 3B), which may influence the therapeutic effect on RA. The gene discussed is AKT1; the disease is rheumatoid arthritis.